Cargando…

Editorial comment to “The value of percentage free prostate-specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria” and Reply by authors

Detalles Bibliográficos
Autores principales: Elabbady, Ahmed, Ezenwa, Ekene V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442942/
https://www.ncbi.nlm.nih.gov/pubmed/26558057
http://dx.doi.org/10.1016/j.aju.2012.06.001
_version_ 1782372945677516800
author Elabbady, Ahmed
Ezenwa, Ekene V.
author_facet Elabbady, Ahmed
Ezenwa, Ekene V.
author_sort Elabbady, Ahmed
collection PubMed
description
format Online
Article
Text
id pubmed-4442942
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-44429422015-11-10 Editorial comment to “The value of percentage free prostate-specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria” and Reply by authors Elabbady, Ahmed Ezenwa, Ekene V. Arab J Urol Oncology/Reconstruction Editorial Elsevier 2012-12 2012-07-17 /pmc/articles/PMC4442942/ /pubmed/26558057 http://dx.doi.org/10.1016/j.aju.2012.06.001 Text en . http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Oncology/Reconstruction Editorial
Elabbady, Ahmed
Ezenwa, Ekene V.
Editorial comment to “The value of percentage free prostate-specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria” and Reply by authors
title Editorial comment to “The value of percentage free prostate-specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria” and Reply by authors
title_full Editorial comment to “The value of percentage free prostate-specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria” and Reply by authors
title_fullStr Editorial comment to “The value of percentage free prostate-specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria” and Reply by authors
title_full_unstemmed Editorial comment to “The value of percentage free prostate-specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria” and Reply by authors
title_short Editorial comment to “The value of percentage free prostate-specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria” and Reply by authors
title_sort editorial comment to “the value of percentage free prostate-specific antigen (psa) in the detection of prostate cancer among patients with intermediate levels of total psa (4.0–10.0 ng/ml) in nigeria” and reply by authors
topic Oncology/Reconstruction Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442942/
https://www.ncbi.nlm.nih.gov/pubmed/26558057
http://dx.doi.org/10.1016/j.aju.2012.06.001
work_keys_str_mv AT elabbadyahmed editorialcommenttothevalueofpercentagefreeprostatespecificantigenpsainthedetectionofprostatecanceramongpatientswithintermediatelevelsoftotalpsa40100ngmlinnigeriaandreplybyauthors
AT ezenwaekenev editorialcommenttothevalueofpercentagefreeprostatespecificantigenpsainthedetectionofprostatecanceramongpatientswithintermediatelevelsoftotalpsa40100ngmlinnigeriaandreplybyauthors